Edwin Moses

Manufactures recyclable polymers

Develops pharmaceuticals and diagnostics products

Provides transformational medical technologies and services

Develops software solutions used for computational methods to discover new leads for drugs

Develops and manufactures pharmaceutical products

Develops and produces antibodies

Developed ion channel modulators and therapeutics

Provides academic training in computer science, life science, and physical science

Functions as a College/University

Develops drugs for pharmaceutical and biotech companies

Provides on-line clinical solutions

Engages in pharmaceutical research and manufactures clinical trial supplies

Keensight is an active manager which focuses on investments in innovative technologies. They invest in companies based on Information and Communications Technologies, particularly as applied to network throughput improvement, networks interconnectivity and convergence, network safety, data storage management and logistics. They have invested in software companies, semi conductors and telecommunications, as well as in medical technology. Their geographic focus is on Europe and particularly France. The firm favors mature businesses and generally participates in second and subsequent financing rounds. They target companies with proven technology, an already established clientele, a leading market position and high-growth potential. They promote the international expansion of their investee companies.

Develops and manufactures pharmaceuticals products

Develops, manufactures and distributes drugs

Engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development

Functions as a private equity fund

Develops biological products

Operates as a research and development company that discovers drugs to treat inner ear disorders

Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer

Develops next-generation protein therapeutics using artificial intelligence, automation and synthetic DNA

Engages in research in biotechnology for developing therapies for respiratory viral infections

Develops transformational therapeutics

Develops and sells cancer immunotherapies

Operates as a biotechnology company which develops novel system for targeted delivery of therapeutic proteins and peptides

Operates as a biotechnology research organization that develops medicines